Fundraising Fox

MedArrive

New York, US Β· Founded 2018 Β· Delaware corporation Β· 7 known investors

MedArrive provides software for scheduling, routing, and real-time tracking of in-home care delivery teams. The platform serves healthcare organizations managing home-based clinical services, helping them optimize logistics, staffing, and scheduling workflows.

Also known as MedArrive, Inc.

Founders & leadership

MedArrive was founded in 2018 by Inna Plumb and Daniel Trigub.

IP
Inna PlumbCo-founder
DT
Daniel TrigubCo-founder

Board

WS
William SullivanBoard director
ACAnnie Case
Annie Casein𝕏Board directorAdvisor at KPCB
AHAndy Harrison
Andy HarrisonBoard director
ABAgneta Breitenstein
Agneta Breitensteinin𝕏Board Member2023–2024Healthcare Advisor at Define Ventures

Investors Β· 7

Reported raises Β· per SEC filings

Form D private placements

$40.8M disclosed across 2 of 3 rounds Β· 2021–2023

β–Ά$8MraisedApr 2023 Β· 1 investors Β· Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • Agneta BreitensteinDirector
  • Inna PlumbExecutive Officer
  • William SullivanDirector
  • Annie CaseDirector
  • Daniel TrigubExecutive Officer, Director
  • Andy HarrisonDirector
Offering amount
$10M
Amount sold
$8M
First sale
Mar 2023
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06c
Full filing on SEC EDGAR β†—
β–Ά$32.8MraisedFeb 2022 Β· 41 investors Β· Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • William SullivanDirector
  • Annie CaseDirector
  • Inna PlumbExecutive Officer
  • Andy HarrisonDirector
  • Dan TrigubExecutive Officer, Director
  • Lynne Chou O'KeefeDirector
Offering amount
$32.8M
Amount sold
$32.8M
First sale
Jan 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR β†—

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Company profile

researched Aug 2026

MedArrive is a healthcare technology company whose platform supports the coordination and execution of care delivered in the home. The current product is positioned as an "operational intelligence" layer spanning three stages: predicting and identifying patients suitable for home-based care (patient identification and qualification, risk-prioritized patient lists, automated eligibility screening, discharge coordination and health system integration); coordinating transitions (referral automation, patient intake automation, benefits and eligibility verification, care handoff workflows); and operating field delivery (scheduling and routing optimization, real-time capacity visibility and provider coordination). It is sold in two configurations: one for health systems managing discharge planning, referrals and post-acute transitions, and one for in-home care providers managing scheduling, workforce utilization and care coordination. The platform integrates with EHRs, care management platforms, and scheduling, analytics and communication tools, and the company states it is AICPA SOC II certified and HIPAA compliant.

Earlier in its history MedArrive operated as a mobile-integrated care management company: it offered a white-labeled care management solution connecting providers and payers with a field network of paramedics, EMTs and other healthcare professionals who conducted in-home visits, supplemented by physician-led telehealth for higher-acuity needs. Services spanned chronic condition management, transitional care, readmission prevention, urgent care, vaccinations, palliative care, diagnostics, health assessments, post-acute care and social-care needs such as transportation, mobility and nutrition assistance, plus partner-delivered services including virtual behavioral health, retinal screening and maternity care. The company described itself as a risk-bearing entity serving primarily Medicaid and dual-eligible beneficiaries. In 2025 MedArrive transitioned away from directly providing care and launched a home care logistics platform developed in partnership with ChristianaCare.

Founding story

Inna Plumb, previously an investment banker at Evercore Partners, a supply chain leader at Blue Apron and an early founding partner at Redesign Health, was exploring ideas to bring insurance-reimbursed care into the home. She found existing home-care models asset-heavy and costly and clinicians reluctant to travel to homes, and concluded that EMS professionals β€” accustomed to driving and entering homes, and underutilized for chronic condition management β€” were well suited to the work. The COVID-19 outbreak in March 2020 prompted her to commit full time; Redesign Health's investment committee funded the seed and introduced Dan Trigub, then leading Uber Health, who became CEO and co-founder.

Business model

MedArrive licenses its care-delivery software platform to healthcare organizations, historically selling a white-labeled care management solution to health plans and providers and, more recently, a logistics and care-transition platform to health systems and in-home care providers. In its earlier model the company contracted with payers as a risk-bearing entity, was reimbursed through insurance rather than consumer payments, and used a network of EMS field providers rather than owned clinical assets to keep the model capital-efficient.

Historically insurance-based rather than consumer-driven, with contracts with payers and risk-bearing providers under which MedArrive assumed risk and was compensated for lowering total cost of care; the current platform is offered as software to health systems and in-home care providers.

Traction

Named health plan and provider relationships have included Molina Healthcare, Centene plans such as Superior HealthPlan (Texas) and HealthNet (California), Bright HealthCare, SCAN Health Plan, Clover Health, the County of Los Angeles Public Health and Millennium Physician Group. In a first-phase program with Molina Healthcare of Texas, MedArrive reported 74% member engagement, a 20% reduction in ED usage, a 5% improvement in member retention, undocumented social-determinants-of-health needs surfaced in 32% of visits, a 50% reduction in hospitalizations and a 90+ NPS. As of November 2021 the company reported home visits across five states β€” California, Florida, New Jersey, North Carolina and Texas.

Latest developments

In March 2026 MedArrive acquired technology assets from Inbound Health, a home care firm that shut down after citing regulatory uncertainty in the federal Acute Hospital Care at Home Program, adding AI-backed care navigation capabilities and new customers; terms were not disclosed. The same day it named Ophir Lotan, formerly chief product officer at Alto Pharmacy and previously at TytoCare, as chief executive, roughly five months after the co-founder CEO stepped down. Earlier, the company moved away from directly delivering care and launched a home care logistics platform built with ChristianaCare.

β–ΈFull profile β€” market position, technology, go-to-market, geography, history, risks & controversies

Market position

Trade press has described MedArrive as one of the more prominent home-based care startups and, per its investor Cobalt Ventures, a leader in health-care-at-home solutions for health plans. The company positions itself against a market backdrop in which McKinsey projected roughly $265 billion of healthcare services could shift into the home by 2025.

Technology

The platform combines predictive patient identification, referral and intake automation, benefits and eligibility verification, care handoff workflows, and scheduling, routing and capacity-management tools for field teams, with integrations into EHRs, care management, scheduling, analytics and communication systems. Earlier versions of the product paired an EMS field-provider network with physician-led telemedicine and integrations with specialized partners for services such as virtual behavioral health, retinal screening and maternity care. Assets acquired from Inbound Health add AI-backed care navigation that uses clinical and operational data to identify patients ready to transition home and match them to appropriate programs.

Go-to-market

Health systems coordinating discharge planning and post-acute transitions, and in-home care providers managing field workforces. Historically the customer base centered on managed Medicaid and Medicare Advantage health plans and risk-bearing providers, serving adult and pediatric members who are largely Medicaid or dual-eligible, medically complex, disengaged or hard to reach.

Geography

Headquartered in New York, with press releases also issued from Irving, Texas. Home visits were conducted across California, Florida, New Jersey, North Carolina and Texas as of November 2021, supported by a national EMS field-provider network.

History

The concept was developed inside the New York healthcare venture incubator Redesign Health, where Inna Plumb, then a partner, pursued a thesis on delivering care in the home efficiently and settled on EMS professionals as an underutilized workforce. Redesign identified Dan Trigub, then head of Uber Health, as a CEO candidate; the two connected during the onset of the COVID-19 pandemic in March 2020 and co-founded the company under earlier working names including ER.Co and Invitation Health. Redesign Health provided seed funding, followed by an extension from Kleiner Perkins and Define Ventures, and the company officially launched in late 2020. It began with COVID-19 vaccinations for homebound patients in California with SCAN in April 2021, closed a $25 million Series A in November 2021, and raised $8 million led by Cobalt Ventures in April 2023. In 2025 the company stopped delivering care directly and shifted to a logistics platform built with ChristianaCare; its co-founder CEO stepped down in about October 2025, and in March 2026 it acquired technology assets from the shuttered Inbound Health and appointed Ophir Lotan as CEO.

Risks & controversies

The company has undergone a business model shift away from direct care delivery to software, plus a CEO transition in 2025-2026. Its adjacent market has been affected by regulatory uncertainty around the CMS Acute Hospital Care at Home program, which expired repeatedly and lapsed during a government shutdown before being extended through September 30, 2030; that uncertainty was cited as the main cause of Inbound Health's closure. MedArrive previously pivoted toward COVID-focused services during the public health emergency and then back, and raised capital in what its CEO described as a difficult funding environment.

Compiled by commissioned research from 8 cited public sources β€” announcements, filings, and press listed under research sources below.

Key figures

latest reported
Additional risk capture (company claim)Jun 202335%
Customer ROI (company claim)Jun 20235 x
Field providers in networkNov 202150,000 providers
Improvement in member retention (Molina Healthcare of Texas program, phase one)Apr 20235%
Increase in PCP engagement (company claim)Jun 202320%
Member engagement rate (Molina Healthcare of Texas program, phase one)Apr 202374%
Reduction in ED usage (Molina Healthcare of Texas program, phase one)Apr 202320%
Reduction in ED utilization (company claim)Jun 202320%
Reduction in hospitalization (company claim)Jun 202330%
Reduction in hospitalizations (Molina Healthcare of Texas program, phase one)Apr 202350%
States with home visitsNov 20215 states
Total funding raised to dateApr 2023$40.5M
Visits surfacing undocumented SDOH needs (Molina Healthcare of Texas program, phApr 202332%

Company-reported or press-reported figures, each dated to when it was claimed β€” not independently audited.

Competitors Β· 4

by search overlap

Companies competing with MedArrive for the same Google search keywords, organic and paid, via search-intersection analysis.

Timeline Β· 11

launches, deals, and filings
Mar 2026
MedArrive acquires technology assets of shuttered Inbound Health

MedArrive purchased assets from defunct home care firm Inbound Health, adding AI-backed care navigation that identifies patients ready to transition home from acute care, plus new customers. Purchase price was not disclosed.

source β†—

Mar 2026
Ophir Lotan named CEO

MedArrive appointed Ophir Lotan, previously chief product officer at Alto Pharmacy and formerly of TytoCare, as chief executive, about five months after the co-founder and former CEO stepped down.

source β†—

Oct 2025
Co-founder and CEO steps down

MedArrive's co-founder and former chief executive departed roughly five months before the March 2026 appointment of a new CEO.

source β†—

Jan 2025
Launch of home care logistics platform with ChristianaCare

MedArrive transitioned away from directly providing care and launched a logistics platform developed in partnership with Delaware-based health system ChristianaCare, including scheduling, provider routing and workforce management tools for home care.

source β†—

Apr 2023
MedArrive raises $8 million led by Cobalt Ventures

Funding led by Cobalt Ventures, a wholly owned subsidiary of Blue Cross and Blue Shield of Kansas City, to support growth, expansion of health plan relationships, team and platform build-out, and entry into new markets.

$8M source β†—

Mar 2023
Partnership with Ouma Health for at-home maternity care

MedArrive partnered with Ouma Health to deliver maternity care to vulnerable populations at home.

source β†—

Dec 2022
Partnership with Superior HealthPlan

MedArrive announced a partnership with Texas-based Superior HealthPlan.

source β†—

Jan 2022
Partnership with Brave Health

MedArrive partnered with Brave Health to combine at-home and behavioral health care services.

source β†—

Nov 2021
$25 million Series A

MedArrive announced a $25 million Series A round to ramp up at-home health services and expand into new states.

$25M source β†—

Apr 2021
In-home COVID-19 vaccination program with SCAN in California

MedArrive began delivering COVID-19 vaccines to homebound patients in California in collaboration with SCAN.

source β†—

Jan 2020
Company officially launches

MedArrive launched in late 2020 with a home care management platform and a network of emergency services workers assisting patients in their homes.

source β†—

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Legal entities Β· 1

corporate structure
MedArriveDelaware

In the news

β–ΈResearch sources Β· 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does MedArrive do?
MedArrive sells an operational intelligence platform that coordinates hospital-to-home transitions and in-home care logistics.
Who founded MedArrive?
MedArrive was founded by Inna Plumb, Daniel Trigub in 2018.
Who are MedArrive's investors?
MedArrive's investors include 7wire Ventures, Cobalt Ventures, Corewell Health Ventures, Declaration Partners, Kleiner Perkins, Define Ventures, Section 32.
How much funding has MedArrive raised?
MedArrive has disclosed $40.8M raised across 2 of its 3 known rounds.
Where is MedArrive headquartered?
MedArrive is headquartered in New York, US.